LIMINATUS PHARMA INC.
Q2 2026 13F Holders
Symbol
LIMN
CUSIP
53271X108
Type
Equity
Class
CL A
Num filers
14
Total reported value, excl. options
$105 k
Compare 2026 Q2 to
2026 Q1
2025 Q4
2025 Q3
2025 Q2
Manager
Report Date
Value ($000)
Shares
Option Type